Conjugates for treating diseases caused by PSMA expressing cells

Abstract The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing 5 cells, such as prostate cancer cells...

Full description

Saved in:
Bibliographic Details
Main Authors Vetzel, Marilynn, Dorton, Ryan, Nelson, Melissa, Leamon, Christopher Paul, Vlahov, Iontcho Radoslavov, Reddy, Joseph Anand, Bloomfield, Alicia
Format Patent
LanguageEnglish
Published 24.02.2022
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Abstract The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing 5 cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.
Bibliography:Application Number: AU20200202904